| Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing LS Kaertner, MB Steinborn, H Kettner, MJ Spriggs, L Roseman, ... Scientific reports 11 (1), 1941, 2021 | 102 | 2021 |
| Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling T Buchborn, H Schröder, V Höllt, G Grecksch Journal of Psychopharmacology 28 (6), 545-552, 2014 | 74 | 2014 |
| Tolerance and tachyphylaxis to head twitches induced by the 5-HT2A agonist 25CN-NBOH in mice T Buchborn, T Lyons, T Knöpfel Frontiers in pharmacology 9, 322715, 2018 | 43 | 2018 |
| Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT2A and glutamate receptor binding sites T Buchborn, H Schröder, DC Dieterich, G Grecksch, V Höllt Behavioural brain research 281, 62-68, 2015 | 25 | 2015 |
| Tolerance to lysergic acid diethylamide: overview, correlates, and clinical implications T Buchborn, G Grecksch, DC Dieterich, V Höllt Neuropathology of Drug Addictions and Substance Misuse, 846-858, 2016 | 11 | 2016 |
| The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner T Buchborn, T Lyons, C Song, A Feilding, T Knöpfel Journal of Psychopharmacology 34 (7), 786-794, 2020 | 9 | 2020 |
| The ego in psychedelic drug action–ego defenses, ego boundaries, and the therapeutic role of regression T Buchborn, HS Kettner, L Kärtner, MW Meinhardt Frontiers in Neuroscience 17, 1232459, 2023 | 5 | 2023 |
| Body mass index (BMI) does not predict responses to psilocybin MJ Spriggs, B Giribaldi, T Lyons, FE Rosas, LS Kärtner, T Buchborn, ... Journal of Psychopharmacology 37 (1), 107-116, 2023 | 3 | 2023 |
| Differential tolerance to lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT)-A matter of serotonin (5-HT) 2A receptor downregulation? T Buchborn, H Schroeder, T Koch, E Kahl, DC Dieterich, G Grecksch, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 389 (SUPPL 1), 63-63, 2016 | 3 | 2016 |
| Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging T Buchborn, T Lyons, C Song, A Feilding, T Knöpfel International Journal of Molecular Sciences 24 (11), 9463, 2023 | 2 | 2023 |
| The Biological Level J Reckweg, MSDL Basedow, C Letheby, MB Jones Ecology, 2020 | | 2020 |
| Verhaltens-und molekularbiologische Untersuchungen zur Grundlage der Toleranz gegenüber serotonergen Halluzinogenen T Buchborn | | 2020 |
| A Lid for Every Pot J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn Biochemistry, 2017 | | 2017 |
| Agonist-selective internalization of the human 5-HT2A receptor T Buchborn, E Kahl, V Hoellt, T Koch NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 385 (SUPPL 1), 17-17, 2012 | | 2012 |
| Chapter VI-Taraxein KL White, BL Roth, AL Halberstadt, MA Geyer, RHA Chan, JE Mendelson, ... Biological Psychiatry 72 (10), 797-798, 2012 | | 2012 |
| A History of Ecstasy Science J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn | | |
| Storia della scienza dell’ecstasy J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn | | |
| HISTORIA BADAŃ ECSTASY J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn | | |
| Una Historia de la Ciencia de éxtasis J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn | | |
| ANTYDEPRESANTY I PSYCHODELIKI J Reckweg, MSDL Basedow, MV Uthaug, PDL Jaeckel, T Buchborn | | |
